US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

166.18

-0.0200-0.01%

Post-market: 166.190.0101+0.01%19:55 EDT

Volume:7.15M

Turnover:1.19B

Market Cap:42.64B

PE:-11.69

High:166.85

Open:166.55

Low:165.27

Close:166.20

52wk High:176.60

52wk Low:141.05

Shares:256.62M

Float Shares:256.62M

Volume Ratio:0.83

T/O Rate:2.79%

Dividend:2.45

Dividend Rate:1.47%

EPS(TTM):-14.2170

EPS(LYR):-14.2170

ROE:-9.22%

ROA:1.03%

PB:1.24

PE(LYR):-11.69

Loading ...

Overview Company News Filings

AbbVie, Iambic Sign Multiyear Drug Discovery Deal

MT Newswires Live

AbbVie Partners with Iambic to Accelerate AI-Driven Small-Molecule Drug Discovery

Johnson & Johnson Says Phase 3 Trial Shows Caplyta Cuts Bipolar I Mania Symptoms by Week 3

Abbvie and Iambic Announce Collaboration to Accelerate AI-Driven Drug Discovery

THOMSON REUTERS

Abbvie - Iambic to Receive Upfront Payment, Milestone Payments, and Tiered Royalties from Collaboration

THOMSON REUTERS

Abbvie - Partnership to Accelerate Small Molecule Drug Discovery in Immunology, Neuroscience, Oncology

THOMSON REUTERS

J&J - Caplyta Demonstrates Statistically Significant Rapid Reduction in Manic Symptoms at Week 3

THOMSON REUTERS

Caplyta® (Lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Pivotal Phase 3 Study

THOMSON REUTERS

J&J - Caplyta Well-Tolerated; Dry Mouth and Nausea Most Common Adverse Events

THOMSON REUTERS

Adarx Pharmaceuticals: IPO Price Expected Between $15 and $17 Per Share

Oura Files for Initial Public Offering on Nasdaq

MT Newswires Live

DRI Healthcare to Buy Tavapadon Royalty for $316 Million

LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals

ADARx Pharmaceuticals to Sell 21.9 Million Shares at $15-$17 Each in IPO

Smart Ring Maker Oura Eyes $15.6 Billion IPO Valuation in Fall Listings Demand Test

Analysts’ Top Healthcare Picks: LeonaBio (LONA), Immunovant (IMVT)

Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing

THOMSON REUTERS

Japan Health Ministry Approves Merck’s Keytruda QLEX for Subcutaneous Use Across Keytruda Indications

Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Approved in Japan for Subcutaneous Administration for All Keytruda® (Pembrolizumab) Indications Approved in Japan

THOMSON REUTERS

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/XLV/news?page=29"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":166.18,"timestamp":1790971200000,"preClose":166.2,"halted":0,"volume":7148329,"hourTrading":{"tag":"盘后","latestPrice":166.1901,"preClose":166.18,"latestTime":"19:55 EDT","volume":82624,"amount":13718838.9734,"timestamp":1790985337084,"change":0.0101,"changeRate":0.000061,"amplitude":0.001565},"delay":0,"changeRate":-0.00012033694344152714,"floatShares":256615324,"shares":256615324,"eps":-14.217021,"marketStatus":"Market Closed","change":-0.02,"latestTime":"10-02 16:00:00 EDT","open":166.545,"high":166.85,"low":165.27,"amount":1186052677.7288299,"amplitude":0.009507,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":166.2,"sharesOutstanding":265215324,"nav":166.093797,"aum":42854744944.19,"dividendRate":0.014714,"bidAskSpread":0.00013,"preHourTrading":{"tag":"盘前","latestPrice":166.58,"preClose":166.2,"latestTime":"09:29 EDT","volume":2214,"amount":368966.5317,"timestamp":1790947799999,"change":0.38,"changeRate":0.002286,"amplitude":0.006078},"postHourTrading":{"tag":"盘后","latestPrice":166.1901,"preClose":166.18,"latestTime":"19:55 EDT","volume":82624,"amount":13718838.9734,"timestamp":1790985337084,"change":0.0101,"changeRate":0.000061,"amplitude":0.001565},"volumeRatio":0.8270119042516672,"impliedVol":0.1983,"impliedVolPercentile":0.6892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":256615324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.8270119042516672,"shares":256615324,"dividePrice":2.44525,"high":166.85,"amplitude":0.009507,"preClose":166.2,"low":165.27,"week52Low":141.05,"pbRate":"1.24","psRate":"64.74","week52High":176.595,"institutionHeld":0.7846,"latestPrice":166.18,"eps":-14.217021,"divideRate":0.014714,"volume":7148329,"delay":0,"ttmEps":-14.217021,"open":166.545,"prevYearClose":154.8,"prevWeekClose":170.7,"prevMonthClose":168.42,"prevQuarterClose":168.42,"fiveDayClose":170.7,"twentyDayClose":173.26,"sixtyDayClose":162.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"XLV","amount":0.642226,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-23"},{"date":"2026-06-22","symbol":"XLV","amount":0.656252,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XLV","amount":0.59468,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.307823,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.304755,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.299668,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:29,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669165127","title":"AbbVie, Iambic Sign Multiyear Drug Discovery Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669165127","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669165127?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:47","pubTimestamp":1789994836,"startTime":"0","endTime":"0","summary":"AbbVie  and Iambic entered a multiyear collaboration to discover and develop small-molecule treatments in immunology, neuroscience and oncology, the companies said Monday.The companies said they will use Iambic's artificial intelligence platform, Enchant v3, to identify potential drug candidates more efficiently.The model, which combines different types of biomedical data and can test multiple drug-design ideas at the same time, was trained on more than 6,000 molecular properties, the companies said.Iambic will receive an upfront payment and is eligible for milestone payments and tiered royalties on net sales of products developed under the collaboration, the companies added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1496350502.SGD","FTXH","MEDX","IE000WAW04H5.SGD","LU1670627923.USD","LU0943347566.SGD","LU2237443382.USD","FHLC","PJP","ABBV","LU2087621335.USD","LU1934455194.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU0553294199.USD","LU0965508806.USD","AGNG","GLAM","LU0738911758.USD","JDOC","LU0795875086.SGD","IE00BVYPNV92.GBP","LU1989772923.USD","LU1244550494.USD","LU0395794307.EUR","LU0289739343.SGD","IE00BDGV0183.EUR","SG9999003800.SGD","LU0098860793.USD","LU0289961442.SGD","RXL","IXJ","LU0310800379.SGD","SG9999015952.SGD","TRUH","LU1551013342.USD","LU0795875169.SGD","LU0942090050.USD","IYH","VHT","LU0256863902.USD","IE00BFTCPJ56.SGD","LU0820561818.USD","LU2237443895.HKD","LU0726765562.USD","PPH","XLV","LU0965509101.SGD","LU0689626769.HKD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163630","title":"AbbVie Partners with Iambic to Accelerate AI-Driven Small-Molecule Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163630","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163630?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:04","pubTimestamp":1789992273,"startTime":"0","endTime":"0","summary":"AbbVie partners with Iambic to accelerate AI-driven small-molecule drug discoveryAbbVie entered a multi-year collaboration with Iambic to accelerate AI-driven discovery of small-molecule drugs across ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8jfSRw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU0726765562.USD","LU2347655156.SGD","VHT","SG9999015978.USD","BK4585","IYH","LU0882574055.USD","RXL","SG9999003800.SGD","ABBV","LU0256863902.USD","LU2237443895.HKD","LU0820561909.HKD","FHLC","TRUH","LU0289739699.SGD","LU0942090050.USD","LU0456855351.SGD","LU0689626769.HKD","GLAM","LU0912757837.SGD","LU0472753341.HKD","LU0795875169.SGD","MEDX","BK4588","LU0198837287.USD","LU0320765646.SGD","IE00B19Z3B42.SGD","LU2237443382.USD","LU0289961442.SGD","FTXH","LU0859254822.USD","LU2347655073.USD","LU1923622614.USD","PJP","LU2357627491.SGD","LU2237443978.SGD","LU1291159041.SGD","XLV","JDOC","LU2357305700.SGD","IXJ","LU0795875086.SGD","IE00BVYPNW00.USD","LU0234572021.USD","AGNG","PPH","SG9999015952.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669304163","title":"Johnson & Johnson Says Phase 3 Trial Shows Caplyta Cuts Bipolar I Mania Symptoms by Week 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2669304163","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669304163?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:01","pubTimestamp":1789992097,"startTime":"0","endTime":"0","summary":"Johnson & Johnson says Phase 3 trial shows Caplyta cuts bipolar I mania symptoms by Week 3Johnson & Johnson reported positive topline Phase 3 results for Caplyta in acute manic episodes tied to bipola","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDLb4JpTd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0964807845.USD","LU2456880835.USD","LU2023250330.USD","IHE","LU1914381329.SGD","LU1066051498.USD","JDOC","IE0001KFT4U8.USD","LU1551013425.SGD","IE00BDGV0183.EUR","MEDX","IE00BJJMRZ35.SGD","LU0124676726.USD","RXL","LU0466842654.USD","LU0203347892.USD","LU1059921491.USD","LU2592432038.USD","LU2471134523.USD","IE00B42XCP33.USD","VHT","IXJ","GDOC","FHLC","FTXH","TRUH","LU0820561818.USD","IE00BJT1NW94.SGD","BMED","LU2430703095.HKD","LU0210528500.USD","IE00B19Z3B42.SGD","LU2236285917.USD","LU0114720955.EUR","LU0345770308.USD","LU1935042991.SGD","JNJ","IE00BFXG1179.USD","LU1244550494.USD","IYH","IE00BVYPNW00.USD","LU0432979614.USD","LU1430594728.SGD","LU0345769128.USD","LU0289961442.SGD","XLV","IE00BLSP4452.SGD","PJP","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669802163","title":"Abbvie and Iambic Announce Collaboration to Accelerate AI-Driven Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2669802163","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669802163?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUABRGQYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1551013342.USD","LU1548497426.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","VHT","IE0004445239.USD","LU0170899867.USD","IYH","LU1003077747.HKD","RXL","BK4581","ABBV","LU0985320562.USD","LU0256863902.USD","LU1244550494.USD","TRUH","FHLC","LU2133065610.SGD","LU0738911758.USD","LU0456855351.SGD","GLAM","LU0949170772.SGD","LU1236620834.HKD","LU1244550577.SGD","LU0310799852.SGD","IE000SO60NU8.SGD","MEDX","IE00B19Z3B42.SGD","LU1057294990.SGD","FTXH","PJP","LU2357627491.SGD","XLV","LU1267930573.SGD","JDOC","IE000MB6IJN5.SGD","IE00B2B36J28.USD","LU1585245621.USD","IXJ","LU1061106388.HKD","IE00BVYPNW00.USD","LU2089284900.SGD","AGNG","IE0002270589.USD","IE00BLSP4239.USD","LU0211328371.USD","LU1162221912.USD","LU2237443549.SGD","PPH","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669516335","title":"Abbvie - Iambic to Receive Upfront Payment, Milestone Payments, and Tiered Royalties from Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669516335","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669516335?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUABRGQYL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0198837287.USD","SG9999015986.USD","IE00BSNM7G36.USD","LU0985320562.USD","LU0511384066.AUD","LU0965509010.AUD","LU0124676726.USD","LU1267930490.SGD","GLAM","LU0122379950.USD","VHT","LU0859254822.USD","LU1551013425.SGD","IE000BZT7R73.USD","ABBV","IYH","LU0726765562.USD","LU0689626769.HKD","LU1720051108.HKD","LU2237443382.USD","SG9999001440.SGD","IE0004445239.USD","LU1162221912.USD","RXL","TRUH","LU2347655073.USD","JDOC","IE0009355771.USD","LU1037948541.HKD","MEDX","LU0310799852.SGD","XLV","LU1923622614.USD","LU1023059063.AUD","IE00BVYPNV92.GBP","LU0965509101.SGD","LU1839511570.USD","IE00B4R5TH58.HKD","AGNG","BK4566","LU1720051017.SGD","PPH","LU0882574055.USD","LU0211327993.USD","PJP","IXJ","LU0069063385.USD","FTXH","FHLC","LU1236620834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163333","title":"Abbvie - Partnership to Accelerate Small Molecule Drug Discovery in Immunology, Neuroscience, Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163333?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUABRGQYL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1162221912.USD","PPH","LU1732799900.SGD","LU0310799852.SGD","JDOC","IE000F7OJYX1.SGD","IE00BJJMRZ35.SGD","TRUH","IE0002141913.USD","LU1548497426.USD","LU1670628061.USD","MEDX","SG9999003800.SGD","RXL","GLAM","LU2347655156.SGD","LU0689472784.USD","ABBV","PJP","IE00BVYPNV92.GBP","LU0708994859.HKD","FTXH","XLV","LU0289739343.SGD","LU0320765646.SGD","IYH","LU2357305700.SGD","AGNG","FHLC","LU0795875169.SGD","VHT","LU1496350171.SGD","LU1093756325.SGD","LU2133065610.SGD","LU0256863902.USD","LU0234570918.USD","LU1291159041.SGD","IE00B4R5TH58.HKD","IE000BZT7R73.USD","LU0820561818.USD","LU0114720955.EUR","IE0009355771.USD","BK4588","BK4550","LU1934455863.HKD","LU2129689431.USD","IXJ","LU1061106388.HKD","LU0289961442.SGD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669353163","title":"J&J - Caplyta Demonstrates Statistically Significant Rapid Reduction in Manic Symptoms at Week 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2669353163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669353163?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0000B7K699.USD","FTXH","LU0795875169.SGD","RXL","LU0689626769.HKD","LU0098860793.USD","LU1291159041.SGD","SG9999013999.USD","FHLC","LU2471134796.USD","LU1430594728.SGD","LU2602419157.SGD","GDOC","BMED","BK4533","LU0345769631.USD","LU0472753341.HKD","LU0943347566.SGD","IE00BFTCPJ56.SGD","IXJ","SGXZ80539844.SGD","LU0640476718.USD","LU0289961442.SGD","LU1935042991.SGD","LU0820561818.USD","MEDX","LU1674673428.USD","IE000SO60NU8.SGD","JDOC","LU2430703178.SGD","XLV","IHE","LU0053666078.USD","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU1267930813.SGD","PJP","IE000BZT7R73.USD","LU1244550221.USD","LU2236285917.USD","BK4504","IE00BZ1G4Q59.USD","IE00BDGV0183.EUR","TRUH","VHT","JNJ","IE00B3PB1722.GBP","LU0426417589.USD","LU2129689431.USD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163800","title":"Caplyta® (Lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Pivotal Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163800?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FHLC","GDOC","JDOC","LU0466842654.USD","LU1043141123.HKD","LU1674673428.USD","LU2403377893.USD","LU0234570918.USD","LU0114720955.EUR","LU1061106388.HKD","LU0345769128.USD","LU2487616109.SGD","IXJ","TRUH","IE0009355771.USD","LU2347655156.SGD","JNJ","PJP","IYH","RXL","LU0210536198.USD","VHT","LU2471134523.USD","LU0795875169.SGD","LU0289961442.SGD","LU0345770993.USD","BK4550","BMED","LU1059921491.USD","SGXZ80539844.SGD","LU0070217475.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU0689472784.USD","LU2471134796.USD","IE00BJJMRZ35.SGD","FTXH","BK4588","LU2129689431.USD","XLV","LU0289739343.SGD","IE0002141913.USD","LU0994945656.USD","IE000F7OJYX1.SGD","IHE","LU0820562030.AUD","LU1267930813.SGD","LU0820561818.USD","BK4504","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163385","title":"J&J - Caplyta Well-Tolerated; Dry Mouth and Nausea Most Common Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163385","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163385?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IYH","FTXH","IE00BFXG1179.USD","LU1629891620.HKD","XLV","LU2213496289.HKD","IE00BVYPNV92.GBP","LU0426417589.USD","IE00B3T34201.USD","LU0640476718.USD","LU0472753341.HKD","BK4588","LU0689626769.HKD","LU1043141123.HKD","IE00BN8TJ469.HKD","FHLC","IE00B42XCP33.USD","LU1121112475.USD","LU1894683264.USD","LU0210528500.USD","LU0124676726.USD","IXJ","LU1989771016.USD","LU2403377893.USD","JNJ","PJP","MEDX","SG9999002232.USD","LU0820562030.AUD","VHT","IE0034235303.USD","LU2468319806.SGD","IE000F7OJYX1.SGD","LU0345769128.USD","TRUH","LU2592432038.USD","BK4585","LU1551013342.USD","LU0122379950.USD","LU0545562505.USD","IHE","GDOC","JDOC","RXL","LU1280957306.USD","IE000SO60NU8.SGD","LU2471134796.USD","BMED","LU1221951129.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163831","title":"Adarx Pharmaceuticals: IPO Price Expected Between $15 and $17 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163831","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163831?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:58","pubTimestamp":1789991885,"startTime":"0","endTime":"0","summary":"BRIEF-Adarx Pharmaceuticals: IPO Price Expected Between $15 And $17 Per ShareSept 21 -AbbVie Inc.ABBV.N:ADARX PHARMACEUTICALS - IPO PRICE EXPECTED BETWEEN $15 AND $17 PER SHARE - SEC FILINGADARX PHARMACEUTICALS - TO OFFER 21,875,000 SHARES IN IPO - SEC FILINGADARX PHARMACEUTICALS - ABBVIE TO PURCHASE 5,007,844 SHARES BASED ON IPO SIZE - SEC FILINGSource text: [ID:n0001193125-26-396007]Further company coverage:ABBV.N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","VHT","IE000BZT7R73.USD","LU1003077747.HKD","LU1023059063.AUD","LU1732799900.SGD","FTXH","LU0795875169.SGD","LU1551013342.USD","AGNG","LU0882574055.USD","LU1983299246.USD","PJP","LU1732800096.USD","LU2347655073.USD","IE0004445239.USD","RXL","LU0965509283.SGD","LU0912757837.SGD","IXJ","LU1244550577.SGD","LU1057294990.SGD","LU1720051108.HKD","TRUH","PPH","LU0320765646.SGD","LU1093756168.USD","IE00B4R5TH58.HKD","LU0203347892.USD","IE00B19Z3581.USD","ABBV","LU0211327993.USD","IYH","LU1236620834.HKD","LU1061106388.HKD","MEDX","LU0122379950.USD","BK4534","IE000SO60NU8.SGD","LU0289739699.SGD","LU1236620750.USD","LU1934455277.USD","LU2089984988.USD","LU2357305700.SGD","LU0432979614.USD","GLAM","JDOC","XLV","LU0158827948.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168714","title":"Oura Files for Initial Public Offering on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168714","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168714?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:48","pubTimestamp":1789991318,"startTime":"0","endTime":"0","summary":"Oura and some of its shareholders plan to offer 50 million common shares at an estimated price of $40 to $44 per share in an initial public offering, the smart ring maker said Monday in a Form S-1 filing.Oura is offering 13.5 million shares, while selling shareholders are offering 36.5 million shares. The underwriters have an option to purchase up to an additional 7.5 million shares from the selling shareholders.The company expects to have 320.9 million shares outstanding immediately after the offering, it said. Oura has applied to list on the Nasdaq Global Select Market under the ticker \"OURA.\"Oura estimates net proceeds of approximately $532.6 million, based on an assumed IPO price of $42 per share.The company plans to use around $526.4 million of the proceeds to cover expected tax withholding and remittance obligations associated with the net settlement of restricted stock units.The remainder will fund general corporate purposes, including technology development, working capital, op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014898.SGD","LU0323591593.USD","LU2491049909.HKD","LU2746668461.USD","LU2491050071.SGD","LU0823434583.USD","LU2237443382.USD","PPH","LU1629891620.HKD","JDOC","FHLC","LU1917777945.USD","LU0823434740.USD","LU0354030511.USD","LU2265009873.SGD","LU0256863811.USD","FTXH","IE00BJLML261.HKD","LU0079474960.USD","LU2089283258.USD","LU2324357040.USD","LU2750360997.AUD","SG9999017495.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","BK4581","LU1712237335.SGD","LU0061475181.USD","LU2361044865.SGD","LU2361045086.USD","LU0203202063.USD","SG9999014880.SGD","LU2361044949.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU2237443549.SGD","LU0114720955.EUR","LU0353189763.USD","SG9999014906.USD","SGXZ99366536.SGD","IE0002141913.USD","LLY","LU0820561909.HKD","LU0964807845.USD","IE0009355771.USD","IE00B775H168.HKD","LU2552382215.SGD","LU1093756168.USD","LU0640476718.USD","IE00BJJMRX11.SGD","IE00BKDWB100.SGD","BK4588","LU0354030438.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0096364046.USD","LU0210536198.USD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","LU2168564065.EUR","BK4007","LU0820562030.AUD","LU0466842654.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0198837287.USD","LU1057294990.SGD","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0203201768.USD","LU0316494557.USD","LU0471298694.HKD","LU2168564495.EUR","LU2271345857.HKD","LU1127390331.HKD","AGNG","LU0385154629.USD","RXL","IE0005OL40V9.USD","LU0708995401.HKD","LU0094547139.USD","LU2756315664.SGD","LU2471134796.USD","SG9999015986.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","LU1868837136.USD","THNR","LU2112291526.USD","OZEM","GB00BDT5M118.USD","LU1069344957.HKD","LU2471134523.USD","SG9999018857.SGD","LU2213496289.HKD","LU1868836591.USD","LU2237443978.SGD","LU2028103732.USD","LU0882574055.USD","LU2089984988.USD","LU2456880835.USD","LU2417539215.USD","IE00B2B36J28.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0787776722.HKD","MHIP","LU1023059063.AUD","LLYX","IE00BWXC8680.SGD","LU0109394709.USD","LU0672654240.SGD","LU2087625088.SGD","LU0158827781.USD","LU2237438978.USD","LU0109391861.USD","LU1691799644.USD","SG9999014914.USD","LU1093756325.SGD","LU1720051108.HKD","SG9999001176.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","MEDX","LU2168564149.EUR","LU1323610961.USD","LU2237443895.HKD","WDNA","ELIS","LU2462591350.SGD","BK4599","SG9999018865.SGD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2756315318.SGD","LU0238689110.USD","LU0345770308.USD","LU2211815571.USD","PJP","LU2462157665.USD","LU0320765992.SGD","LU0345770993.USD","LU1366192091.USD","LU2750360641.GBP","SGXZ81514606.USD","LU0820561818.USD","LLII","LU1061106388.HKD","LU1145028129.USD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2491050154.USD","LU2552382132.HKD","SG9999015952.SGD","LU2746668974.SGD","LU0456855351.SGD","LU0106261372.USD","LU2063271972.USD","VHT","XLV","BK4534","LU2023250330.USD","LU1979441026.SGD","LU1548497426.USD","LU0289739699.SGD","LU0158827948.USD","HRTS","LU0943347566.SGD","LU1551013342.USD","LU0174119429.USD","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999013999.USD","LU0689472784.USD","SG9999015945.SGD","SG9999001176.USD","CANC","IE0001KFT4U8.USD","OURA","IE00BJJMRY28.SGD","LU1983299246.USD","LU2468319806.SGD","LLYZ","LU0823416689.USD","LU1064131342.USD","LU1623119135.USD","IE00B7KXQ091.USD","TMED","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0471298777.SGD","LU2360106947.USD","LU1232071149.USD","LU1868836757.USD","LU1989771016.USD","LU2023250504.SGD","IHE","LU2264538146.SGD","ILDR","LU1280957306.USD","LU0882574139.USD","LU2471134952.CNY","LU2236285917.USD","GDOC","IE00B4R5TH58.HKD","IYH","LU0266013472.USD","LU0889565916.HKD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU0432979614.USD","BK4516","LU1035775433.USD","IE00BN29S564.USD","LU1804176565.USD","LU0097036916.USD","MEDI","CURE","IE00BJT1NW94.SGD","LU0058720904.USD","LU2168563687.JPY","IE0004445015.USD","LU1988902786.USD","LU2602419157.SGD","LU1868836914.USD","LU0683600562.USD","LU2471134879.HKD","ELIL","TRUH","LU2089284900.SGD","LU2461242641.AUD","LU0133085943.USD","LU0353189680.USD","SG9999015978.USD","IE0004445239.USD","IXJ","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168991","title":"DRI Healthcare to Buy Tavapadon Royalty for $316 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168991","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168991?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:33","pubTimestamp":1789990380,"startTime":"0","endTime":"0","summary":"DRI Healthcare Trust reached a $316 million deal to buy certain royalty participation rights in U.S. net sales of tavapadon, an investigational Parkinson's disease drug candidate.The Toronto-based pharmaceutical royalty company on Monday said it entered into purchase agreements to acquire the royalty participation rights from funds managed by Bain Capital and NovaQuest Capital Management, subject to approval of tavapadon by the U.S. Food and Drug Administration.The acquisition will entitle DRI Healthcare to receive tiered royalty payments on annual U.S. net sales of tavapadon, at combined tiered, mid-single digit to low-double digit royalty rates. DRI Healthcare will also be entitled to receive certain sales milestone payments on first reaching certain cumulative U.S. net sales thresholds and four annual fixed payments of $23.4 million on the first four anniversaries of FDA approval of tavapadon. Aggregate receipts are subject to a contractual hard cap of $437.5 million.In August, DRI ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","HCSG","BK4588","LABU","BK4581","LU0029874061.USD","BK4137","BK4585","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150072","title":"LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150072?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:19","pubTimestamp":1789989597,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-Big Beauty faces growing threat from AI, smaller rivalsAdds blog postSTOXX 600 up 1.1%, tech leads, up 2.2%Wall St futures climbFunds cut bearish bets on Japan's yen in latest weekWelcome","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0PF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","FTXH","IE000M9KFDE8.USD","LU1121112475.USD","RXL","LU0912757837.SGD","LU0985320562.USD","LU0738911758.USD","LU1261432733.SGD","LU1732800096.USD","GLAM","FHLC","LU2602419157.SGD","LU0553294199.USD","GDOC","LU0162691827.USD","BMED","IE00BN8TJ469.HKD","IE0002270589.USD","LU0820561909.HKD","LU0949170772.SGD","BK4533","LU0795875086.SGD","LU1066051225.USD","LU2471134952.CNY","LU0943347566.SGD","IXJ","LU1629891620.HKD","LU0640476718.USD","LU0690374615.EUR","MEDX","IE00BLSP4239.USD","LU1674673428.USD","JDOC","LU1551013425.SGD","LU2430703178.SGD","IHE","XLV","IE00B3T34201.USD","PJP","EL","LU1066051498.USD","TRUH","VHT","BK4581","JNJ","IE00B4R5TH58.HKD","IE00BKVL7J92.USD","LU0820562030.AUD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669500261","title":"ADARx Pharmaceuticals to Sell 21.9 Million Shares at $15-$17 Each in IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669500261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669500261?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:17","pubTimestamp":1789989420,"startTime":"0","endTime":"0","summary":"ADARx Pharmaceuticals on Monday said it plans to sell nearly 21.9 million shares at between $15 and $17 apiece in its initial public offering.At the $16 midpoint of that price range, the San Diego cli","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU1496350171.SGD","LU0689626769.HKD","LU2357305700.SGD","IE0002141913.USD","JDOC","BK4559","FHLC","ABBV","LU0203347892.USD","IE00BSNM7G36.USD","LU1670628061.USD","PPH","RXL","TRUH","XLV","KCE","BK4585","LU0289961442.SGD","LU0203345920.USD","LU0320765646.SGD","LU1037948541.HKD","LU0211327993.USD","LU0823416689.USD","LU2237443549.SGD","GLAM","IE000BZT7R73.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","IXJ","MEDX","REDS","FRHC","LU0708994859.HKD","LU2087621335.USD","PJP","LU2237443622.USD","LU1983299246.USD","IPOS","LU1496350502.SGD","VHT","LU0234572021.USD","LU2237443465.HKD","SG9999001440.SGD","LU0943347566.SGD","LU1934455863.HKD","FTXH","LU2023251221.USD","LU2125909247.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669502481","title":"Smart Ring Maker Oura Eyes $15.6 Billion IPO Valuation in Fall Listings Demand Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669502481","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669502481?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:12","pubTimestamp":1789989158,"startTime":"0","endTime":"0","summary":"UPDATE 3-Oura targets $15.62 billion valuation in US IPO, setting stage for fall listingsSept 21 (Reuters)-Ourais targeting a fully diluted valuation of $15.62 billion in its US initial public...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","IE00BZ1G4Q59.USD","LU2602419157.SGD","XLV","MHIP","LU0456855351.SGD","LU2023250330.USD","LLYX","LU1232071149.USD","MEDX","LU0417517546.SGD","IE00B7KXQ091.USD","LU1868837300.USD","PPH","LU1244550577.SGD","LU2089283258.USD","RXL","OURA","LU2265009873.SGD","IXJ","PJP","HRTS","IE0002141913.USD","CURE","LU1069344957.HKD","WDNA","LLY","GSX","KBWB","GDOC","LU2133065610.SGD","IAI","FHLC","THNR","TRUH","OZEM","IYH","SG9999013999.USD","FTXH","CANC","MEDI","TMED","AGNG","IHE","LLII","ILDR","LLYZ","ELIL","VHT","ELIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150016","title":"Analysts’ Top Healthcare Picks: LeonaBio (LONA), Immunovant (IMVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150016?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988431,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LeonaBio (LONA), Immunovant (IMVT) and Edwards Lifes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-leonabio-lona-immunovant-imvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-leonabio-lona-immunovant-imvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XLV","IMVT","LABU","BK4581","BK4139","LU0029874061.USD","BK4585","BK4588","HCSG","LONA","BK4007","LU0128526141.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150396","title":"Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150396","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150396?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:56","pubTimestamp":1789988165,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45C050:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0820561909.HKD","LU0210536198.USD","AGNG","LU2361044865.SGD","LU2468319806.SGD","LU2089984988.USD","LU2237443895.HKD","FHLC","LU2237438978.USD","SGXZ99366536.SGD","LU0820561818.USD","IE00BJT1NW94.SGD","MEDI","BK4516","LU0094547139.USD","LU0097036916.USD","IE0001KFT4U8.USD","SGXZ51526630.SGD","LU0106261372.USD","LU2462157665.USD","LU1232071149.USD","LU1983299246.USD","LU0640476718.USD","LU2471134879.HKD","BK4007","LU0708995401.HKD","LU0466842654.USD","LU2087625088.SGD","LU2168564495.EUR","IHE","LU1988902786.USD","IE00B4R5TH58.HKD","GDOC","LU1061106388.HKD","LU1720051017.SGD","IE00B2B36J28.USD","LU0786609619.USD","LU2357305700.SGD","LU0122379950.USD","SG9999018857.SGD","SG9999014880.SGD","LU2112291526.USD","LU1804176565.USD","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU0353189763.USD","IE00BKDWB100.SGD","IXJ","LU0823416689.USD","LU2417539215.USD","LU1323610961.USD","PPH","LU2237443382.USD","IYH","LU0316494557.USD","LU0198837287.USD","LU0689472784.USD","LU0225283273.USD","BK4588","SG9999001176.USD","LU0823434583.USD","LU0109391861.USD","LU2063271972.USD","LU0320765992.SGD","BK4599","LU0256863811.USD","LU0079474960.USD","LU1093756325.SGD","LU2237443549.SGD","LU2756315318.SGD","LU2462591350.SGD","LU2456880835.USD","IE00BK4W5M84.HKD","LU0256863902.USD","SGXZ81514606.USD","LU2271345857.HKD","LU2023250504.SGD","IE0009355771.USD","LU0345770308.USD","LU0320765059.SGD","LU0820562030.AUD","LU1291159041.SGD","LU2552382132.HKD","LU2602419157.SGD","LU2471134952.CNY","XLV","TRUH","LU0133085943.USD","LU2552382058.USD","LU0158827948.USD","LU2237443978.SGD","OZEM","LU0787776722.HKD","IE00B1XK9C88.USD","BK4581","LU1712237335.SGD","SGXZ31699556.SGD","IE00BJJMRY28.SGD","LU0964807845.USD","LU1069344957.HKD","LU2264538146.SGD","LU2491050071.SGD","LU0471298694.HKD","LU0289739699.SGD","LU2461242641.AUD","LU2023250330.USD","LU1035775433.USD","LU0174119429.USD","LU0109394709.USD","RXL","SGXZ57979304.SGD","IE0004445239.USD","IE0005OL40V9.USD","LLII","IE00B4JS1V06.HKD","VHT","IE00B1BXHZ80.USD","LU2360106947.USD","LU1267930730.SGD","LU1917777945.USD","LU0823434740.USD","LU1979441026.SGD","THNR","SG9999015952.SGD","LU2106854487.HKD","LU2168564065.EUR","IE00B775H168.HKD","LU2168564222.USD","LU2552382215.SGD","LU0456855351.SGD","LU0058720904.USD","LU2756315664.SGD","LU1868836591.USD","IE00BFSS8Q28.SGD","LU2491050154.USD","BK4533","LU1548497426.USD","IE00BKPKM429.USD","LU2265009873.SGD","LU2111349929.HKD","BK4534","LU0266013472.USD","LU0096364046.USD","LLYX","LU0432979614.USD","LU1629891620.HKD","SG9999014914.USD","LU0672654240.SGD","CURE","IE00BJJMRX11.SGD","LU0158827781.USD","LU1868837136.USD","SG9999015986.USD","LU1366192091.USD","LU1145028129.USD","IE0002141913.USD","PJP","WDNA","ELIL","JDOC","LU2213496289.HKD","LU2361044949.HKD","LU2896262040.SGD","MEDX","LU0203202063.USD","CANC","LU0114720955.EUR","LU0354030438.USD","LU2237443465.HKD","LU1064131342.USD","LU0203201768.USD","SG9999017495.SGD","SG9999014906.USD","LU2028103732.USD","LU2361045086.USD","SG9999014898.SGD","LU0417517546.SGD","LU1868836914.USD","LU1093756168.USD","LU1720051108.HKD","IE00BJJMRZ35.SGD","LU2023251221.USD","LU2089283258.USD","MHIP","ILDR","IE00BWXC8680.SGD","LU1814569148.SGD","LU0683600562.USD","LLYZ","LU0061475181.USD","LU0385154629.USD","TMED","IE00BJLML261.HKD","LU2746668461.USD","LU2746668974.SGD","SG9999013999.USD","LU1551013425.SGD","FTXH","LU0006306889.USD","LU1057294990.SGD","HRTS","LU0345770993.USD","LU2324357040.USD","LU2108987350.USD","BK4585","LU0238689110.USD","LU1623119135.USD","LU2471134523.USD","LU2750360641.GBP","LU2089284900.SGD","LU1127390331.HKD","SG9999015945.SGD","LU0882574139.USD","LU0353189680.USD","LU1868837300.USD","LU1280957306.USD","LU0234572021.USD","LU2237443622.USD","SG9999018865.SGD","LU1691799644.USD","LU2168563687.JPY","LU2750360997.AUD","LLY","ELIS","LU0889565916.HKD","LU2211815571.USD","SG9999001176.SGD","LU2491049909.HKD","LU0354030511.USD","LU2236285917.USD","IE0004445015.USD","LU0471298777.SGD","LU0943347566.SGD","LU2168564149.EUR","LU2471134796.USD","LU0882574055.USD","LU0323591593.USD","IE00BN29S564.USD","IE00B7KXQ091.USD","LU1974910355.USD","IE00BFSS7M15.SGD","LU1989771016.USD","OURA","LU1868836757.USD","SG9999015978.USD","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157714","title":"Japan Health Ministry Approves Merck’s Keytruda QLEX for Subcutaneous Use Across Keytruda Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157714","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157714?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:46","pubTimestamp":1789987585,"startTime":"0","endTime":"0","summary":"Japan health ministry approves Merck’s Keytruda QLEX for subcutaneous use across Keytruda indicationsJapan’s health ministry cleared Merck’s subcutaneous Keytruda QLEX for all Keytruda indications app","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL9c8jcM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014575.USD","LU2023250504.SGD","LU0203347892.USD","VHT","LU1983299246.USD","LU1941712348.USD","LU1934455194.USD","LU2125154935.USD","LU1989772840.SGD","LU2361044865.SGD","LU2491050071.SGD","SG9999001176.USD","LU0432979614.USD","LU1037948897.HKD","LU0320765646.SGD","LU0320765489.SGD","LU0511384066.AUD","LU1035773651.USD","LU0965508806.USD","LU0965509283.SGD","SG9999015341.SGD","LU0069063385.USD","LU0289961442.SGD","LU0130517989.USD","LU2023250843.SGD","IHE","LU2361044949.HKD","IE00BLSP4239.USD","LU0823416689.USD","IE00BJT1NW94.SGD","TRUH","IXJ","IE00BSNM7G36.USD","LU0203345920.USD","LU1032466523.USD","IYH","LU0130102774.USD","LU1934455863.HKD","IE00BLSP4452.SGD","IE00B2B36J28.USD","BK4533","LU0124676726.USD","LU0942090050.USD","SG9999002232.USD","LU1201861249.SGD","LU1023059063.AUD","LU1116320737.USD","LU1934455277.USD","LU0965509010.AUD","LU0689626769.HKD","LU0208291251.USD","LU0985320562.USD","LU0861579265.USD","LU2468319806.SGD","LU0058720904.USD","BK4550","LU0234572021.USD","LU0477156953.USD","LU0106261372.USD","LU2112291526.USD","LU2125909247.SGD","LU1585245621.USD","LU1093756325.SGD","LU2324357040.USD","SG9999001440.SGD","SG9999014567.USD","BK4534","LU2461242641.AUD","LU2125154778.USD","PAWZ","PPH","LU2357627491.SGD","LU0057025933.USD","LU0868494617.USD","SG9999013999.USD","LU0265550359.USD","LU1066051225.USD","LU1941712264.USD","LU1061106388.HKD","BMED","LU2089984988.USD","SG9999001176.SGD","XLV","LU1066053197.SGD","LU1571399168.USD","LU1923622614.USD","LU0238689110.USD","IE00BBT3K403.USD","SG9999014559.SGD","HRTS","IE00BFTCPJ56.SGD","LU1066051498.USD","SGXZ57979304.SGD","LU1116320901.HKD","LU2491050154.USD","BK4516","LU2433249047.HKD","LU1057294990.SGD","GDOC","SG9999002224.SGD","IE0002141913.USD","LU0006306889.USD","IE00BJJMRZ35.SGD","LU2491049909.HKD","JDOC","IE000M9KFDE8.USD","RXL","LU1430594728.SGD","LU1989772923.USD","LU1699723380.USD","LU2360032135.SGD","BK4585","LU0266013472.USD","LU2361045086.USD","LU1929549753.HKD","LU1162221912.USD","FTXH","LU1989771016.USD","LU0122379950.USD","LU0072461881.USD","LU0868494708.USD","IE0009355771.USD","LU0211331839.USD","LU1037948541.HKD","LU1069347547.HKD","FHLC","LU1066051811.HKD","LU0289739343.SGD","LU0289739699.SGD","LU1291159041.SGD","LU1917777945.USD","IE00BN8TJ469.HKD","LU0859254822.USD","LU0162691827.USD","SG9999015358.SGD","LU0648001328.SGD","IE00B1BXHZ80.USD","LU0098860793.USD","LU2125909593.SGD","LU0965509101.SGD","BK4588","LU0980610538.SGD","LU0472753341.HKD","LU0070302665.USD","LU1093756168.USD","LU2106854487.HKD","MRK","IE00B4R5TH58.HKD","BK4007","LU0265550946.USD","BK4559","LU1974910355.USD","SG9999014542.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669215775","title":"Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Approved in Japan for Subcutaneous Administration for All Keytruda® (Pembrolizumab) Indications Approved in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2669215775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669215775?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:45","pubTimestamp":1789987500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9WPNHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGXZ57979304.SGD","BK4550","LU1989772923.USD","SG9999001176.SGD","LU1291159041.SGD","RXL","LU0162691827.USD","LU1162221912.USD","LU1941712264.USD","LU1066051811.HKD","LU2324357040.USD","LU2357627491.SGD","LU1093756325.SGD","LU0265550359.USD","LU2361044865.SGD","BK4588","XLV","LU0985320562.USD","BK4516","PPH","LU2360032135.SGD","IE0002141913.USD","SG9999014567.USD","FTXH","LU2491049909.HKD","LU0965509101.SGD","LU1069347547.HKD","VHT","IE0009355771.USD","LU2023250504.SGD","BK4585","LU0289739343.SGD","LU0823416689.USD","SG9999013999.USD","GDOC","LU0058720904.USD","IE00BLSP4452.SGD","LU0124676726.USD","LU0069063385.USD","BK4534","LU0072461881.USD","LU1057294990.SGD","LU1585245621.USD","LU1061106388.HKD","SG9999014542.SGD","SG9999014575.USD","BK4559","LU2491050154.USD","LU2361045086.USD","LU0234572021.USD","LU1116320901.HKD","LU0861579265.USD","LU0106261372.USD","LU0070302665.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0208291251.USD","LU2433249047.HKD","SG9999014559.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125909247.SGD","BK4533","LU1035773651.USD","LU1093756168.USD","HRTS","LU0320765646.SGD","LU0689626769.HKD","LU0238689110.USD","LU1934455194.USD","LU1201861249.SGD","LU1430594728.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0320765489.SGD","MRK","IE000M9KFDE8.USD","LU0289739699.SGD","LU0211331839.USD","LU1923622614.USD","LU1974910355.USD","LU0859254822.USD","LU0965508806.USD","LU1917777945.USD","LU0265550946.USD","IXJ","LU1934455277.USD","SG9999001176.USD","LU2125909593.SGD","LU2125154935.USD","LU0511384066.AUD","LU1571399168.USD","IE00BJT1NW94.SGD","TRUH","LU0648001328.SGD","SG9999015341.SGD","LU0432979614.USD","LU0942090050.USD","IE00B2B36J28.USD","LU0130102774.USD","LU2125154778.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","LU0980610538.SGD","LU2112291526.USD","LU0098860793.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","PAWZ","LU0122379950.USD","IE00BBT3K403.USD","LU0057025933.USD","SG9999002232.USD","JDOC","LU2106854487.HKD","LU2089984988.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","SG9999015358.SGD","BMED","LU0006306889.USD","LU0868494708.USD","SG9999002224.SGD","IYH","LU1066053197.SGD","LU1989772840.SGD","LU1037948541.HKD","LU0965509283.SGD","IE00BLSP4239.USD","LU0868494617.USD","IHE","LU1929549753.HKD","BK4007","IE00BN8TJ469.HKD","LU0472753341.HKD","LU1066051225.USD","LU2491050071.SGD","LU0130517989.USD","FHLC","LU1023059063.AUD","LU0965509010.AUD","LU1983299246.USD","LU0203345920.USD","LU1699723380.USD","LU0477156953.USD","LU2361044949.HKD","LU1066051498.USD","LU1116320737.USD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157222","title":"Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157222","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157222?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:44","pubTimestamp":1789987466,"startTime":"0","endTime":"0","summary":"Novo says its next-gen obesity drug tops Lilly rival in late-stage studySept 21 (Reuters)-Novo NordiskNOVOb.COsaid on Monday its next-generation experimental drug had achieved an estimated average weight loss of 12.4% in a late-stage trial and that it was superior to Eli Lilly'sLLY.Ndrug.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJJMRX11.SGD","FTXH","LU0289739699.SGD","LU0316494557.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1323610961.USD","BK4599","IE0002141913.USD","LU1145028129.USD","LU1035775433.USD","SG9999014898.SGD","LU2471134523.USD","LU2552382058.USD","LU0820562030.AUD","MHIP","LU0198837287.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0106261372.USD","LLYX","LU2491050154.USD","BK4588","CANC","LU1989771016.USD","LU2112291526.USD","AGNG","LU2271345857.HKD","LU0154236417.USD","LU2023250504.SGD","LU0323591593.USD","LU0353189763.USD","LU1917777945.USD","LU2237443465.HKD","LU2357305700.SGD","LU0345770308.USD","LU0823434740.USD","LU1057294990.SGD","LU1623119135.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2213496289.HKD","SG9999015952.SGD","LU1551013342.USD","LU0061475181.USD","LU0058720904.USD","SGXZ81514606.USD","IYH","LU0234572021.USD","ELIS","LU0006306889.USD","LU0882574055.USD","LU0109391861.USD","LU2089283258.USD","IE00BKVL7J92.USD","LU0097036916.USD","LU0708995401.HKD","LU2756315318.SGD","LU2089984988.USD","SG9999015978.USD","LU2111349929.HKD","LU1548497426.USD","LU2746668461.USD","LU0466842654.USD","LU2750360997.AUD","LU0210536198.USD","MEDX","LU2063271972.USD","SG9999013999.USD","LU0943347566.SGD","IHE","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU2471134796.USD","LU0640476718.USD","LU0122379950.USD","LU0432979614.USD","LU0823416689.USD","LU1814569148.SGD","LU0225283273.USD","LU1868836914.USD","LU2023250330.USD","LU1629891620.HKD","LU2265009873.SGD","LU0079474960.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999014906.USD","LU2237443978.SGD","JDOC","LU2462591350.SGD","LU0964807845.USD","LU2461242641.AUD","LU2471134879.HKD","LU2552382215.SGD","LU2552382132.HKD","LU0203202063.USD","LU0345770993.USD","NVOH","LU1291159041.SGD","LU2491050071.SGD","LLY","LU1267930730.SGD","LLII","SG9999014914.USD","TRUH","LU1127390331.HKD","VHT","LU1868837136.USD","LU2023251221.USD","SG9999015986.USD","LU0256863902.USD","SGXZ51526630.SGD","IE00B1XK9C88.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2236285917.USD","LU2237443895.HKD","LU2361044949.HKD","LU0672654240.SGD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0158827948.USD","SG9999014880.SGD","LU2089284900.SGD","LU1023059063.AUD","NVOC","ELIL","LU2324357040.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2237443382.USD","PJP","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU0094547139.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1988902786.USD","LU2360106947.USD","TMED","NVOX","LU2361045086.USD","HRTS","LU1712237335.SGD","SG9999018857.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU1868836591.USD","LU2896262040.SGD","LU1868836757.USD","LU0417517546.SGD","LU0823434583.USD","LU2168564149.EUR","LU2264538146.SGD","IE0009355771.USD","LU0385154629.USD","LU2417539215.USD","LU2237443549.SGD","LU2756315664.SGD","IE00BKDWB100.SGD","RXL","IE0004445015.USD","LU0133085943.USD","LU1979441026.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0471298777.SGD","IE00B7KXQ091.USD","CURE","ILDR","LU0689472784.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU1551013425.SGD","IE0001KFT4U8.USD","WDNA","LU0203201768.USD","LU2602419157.SGD","LU0683600562.USD","LU2168564495.EUR","IE00BN29S564.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018865.SGD","LU1064131342.USD","LU1691799644.USD","LU0109394709.USD","FHLC","SG9999017495.SGD","THNR","MEDI","IE00B4JS1V06.HKD","LU0320765059.SGD","BK4534","IE00BWXC8680.SGD","LU1983299246.USD","LU2237438978.USD","LU2746668974.SGD","LU1720051108.HKD","LU0787776722.HKD","OZEM","LLYZ","LU1061106388.HKD","LU0353189680.USD","LU0820561909.HKD","BK4532","GDOC","BK4581","LU0456855351.SGD","LU1974910355.USD","LU1804176565.USD","LU2491049909.HKD","IXJ","LU0174119429.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","SG9999001176.USD","LU2456880835.USD","IE00B775H168.HKD","LU1868837300.USD","LU2750360641.GBP","LU2462157665.USD","NVO","LU0820561818.USD","LU2237443622.USD","LU2471134952.CNY","SG9999015945.SGD","LU1093756168.USD","LU0786609619.USD","LU2361044865.SGD","PPH","BK4533","LU1069344957.HKD","LU2087625088.SGD","SGXZ99366536.SGD","XLV","LU2028103732.USD","LU0354030511.USD","LU2108987350.USD","IE0004445239.USD","LU0471298694.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":30,"pageCount":29,"totalSize":594,"code":"91000000","status":"200"}]}}